Long-term efficacy and safety of guselkumab, a monoclonal antibody specific to the p19 subunit of interleukin-23, through two years: results from a phase III, randomized, double-blind, placebo-controlled study conducted in biologic-naive patients with active Psoriatic Arthritis

Autor: McInnes, I.B., Rahman, P., Gottlieb, A.B., Hsia, E.C., Kollmeier, A.P., Xu, X.L., Jiang, Y.S., Sheng, S.H., Shawi, M., Chakravarty, S.D., Heijde, D. van der, Mease, P.J.

Publikováno v: Arthritis & Rheumatology, 74(3), 475-485. WILEY

Objective To assess long-term efficacy and safety of guselkumab, an interleukin-23 p19 subunit (IL-23p19) inhibitor, in patients with active psoriatic arthritis (PsA) from the phase III DISCOVER-2 trial. Methods In the DISCOVER-2 trial, patients with

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=narcis______::bf491dbe6c60ff45c19ca24380da1779
http://hdl.handle.net/1887/3276429

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Fast Clinical Response of Bimekizumab in Nail Psoriasis: A Retrospective Multicenter 36-Week Real-Life Study.

Autor: Campione, Elena¹ (AUTHOR) elena.campione@uniroma2.it, Artosi, Fabio¹ (AUTHOR) ruslanagaetashumak@gmail.com, Shumak, Ruslana Gaeta¹ (AUTHOR) alessandro.giunta@uniroma2.it, Giunta, Alessandro¹ (AUTHOR) luca.bianchi@uniroma2.it, Argenziano, Giuseppe² (AUTHOR) giuseppe.argenziano@unicampania.it, Assorgi, Chiara³ (AUTHOR) chiara.assorgi@uniroma1.it, Balato, Anna² (AUTHOR) anna.balato@unicampania.it, Bernardini, Nicoletta³ (AUTHOR) nicoletta.bernardini@libero.it, Brunasso, Alexandra Maria Giovanna⁴ (AUTHOR) alexandra.brunasso@galliera.it, Burlando, Martina⁵ (AUTHOR) martina.burlando@unige.it, Caldarola, Giacomo^6,7 (AUTHOR) giacomo.caldarola@policlinicogemelli.it, Campanati, Anna⁵ (AUTHOR) info@clinicadermatologicancona.it, Carugno, Andrea⁸ (AUTHOR) acarugno@asst-pg23.it, Castelli, Franco⁹ (AUTHOR) franco.castelli@hotmail.it, Conti, Andrea⁹ (AUTHOR) a.conti.dermo@gmail.com, Costanzo, Antonio¹⁰ (AUTHOR) antonio.costanzo@hunimed.eu, Cuccia, Aldo¹¹ (AUTHOR) dott.aldocuccia@gmail.com, Dapavo, Paolo¹² (AUTHOR) paolo.dapavo@gmail.com, Dattola, Annunziata¹³ (AUTHOR) nancydattola@gmail.com, De Simone, Clara^6,7 (AUTHOR) clara.desimone@unicatt.it

Publikováno v: Pharmaceuticals (14248247). Oct2024, Vol. 17 Issue 10, p1378. 18p.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.